VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 10/31/2022 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 4.98M | 4.98M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 4.98M | 4.98M |
| Cost of Revenue | -- | -- | -- | 2.95M | 2.95M |
| Gross Profit | -- | -- | -- | 2.03M | 2.03M |
| SG&A Expenses | -- | -- | -- | 852.50K | 852.80K |
| Depreciation & Amortization | -- | -- | -- | 3.80K | 3.80K |
| Other Operating Expenses | -- | -- | -- | 400.00 | 400.00 |
| Total Operating Expenses | -- | -- | -- | 3.80M | 3.80M |
| Operating Income | -- | -- | -- | 1.17M | 1.17M |
| Income Before Tax | -- | -- | -- | 1.18M | 1.18M |
| Income Tax Expenses | -- | -- | -- | 246.00K | 246.00K |
| Earnings from Continuing Operations | -- | -- | -- | 0.94 | 0.94 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | 936.00K | 935.70K |
| EBIT | -- | -- | -- | 1.17M | 1.17M |
| EBITDA | -- | -- | -- | 1.19M | 1.19M |
| EPS Basic | -- | -- | -- | 0.00 | 0.00 |
| Normalized Basic EPS | -- | -- | -- | 0.00 | 0.00 |
| EPS Diluted | -- | -- | -- | 0.00 | 0.00 |
| Normalized Diluted EPS | -- | -- | -- | 0.00 | 0.00 |
| Average Basic Shares Outstanding | -- | -- | -- | 826.09M | 826.09M |
| Average Diluted Shares Outstanding | -- | -- | -- | 826.09M | 826.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |